[PPB] YoY Annualized Quarter Result on 31-Dec-2010 [#4]

Announcement Date
28-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- -18.33%
YoY- 16.65%
Quarter Report
View:
Show?
Annualized Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 3,312,917 3,017,926 2,710,539 2,274,036 2,053,769 2,488,566 2,989,442 1.72%
PBT 1,063,417 916,814 1,056,580 1,131,486 1,455,390 1,220,339 563,936 11.14%
Tax -72,478 -48,617 -44,072 777,740 173,649 73,085 6,438,576 -
NP 990,939 868,197 1,012,508 1,909,226 1,629,039 1,293,424 7,002,512 -27.79%
-
NP to SH 982,573 842,152 980,372 1,884,949 1,615,964 1,286,509 6,972,965 -27.84%
-
Tax Rate 6.82% 5.30% 4.17% -68.74% -11.93% -5.99% -1,141.72% -
Total Cost 2,321,978 2,149,729 1,698,031 364,810 424,730 1,195,142 -4,013,070 -
-
Net Worth 15,649,523 14,273,418 14,060,028 13,277,624 14,083,818 12,234,401 11,428,151 5.37%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 296,392 237,099 272,664 1,043,241 865,419 1,007,678 355,647 -2.98%
Div Payout % 30.16% 28.15% 27.81% 55.35% 53.55% 78.33% 5.10% -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 15,649,523 14,273,418 14,060,028 13,277,624 14,083,818 12,234,401 11,428,151 5.37%
NOSH 1,185,569 1,185,499 1,185,499 1,185,502 1,185,506 1,185,504 1,185,492 0.00%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 29.91% 28.77% 37.35% 83.96% 79.32% 51.97% 234.24% -
ROE 6.28% 5.90% 6.97% 14.20% 11.47% 10.52% 61.02% -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 279.44 254.57 228.64 191.82 173.24 209.92 252.17 1.72%
EPS 82.88 71.04 82.70 159.00 136.31 108.52 588.19 -27.84%
DPS 25.00 20.00 23.00 88.00 73.00 85.00 30.00 -2.99%
NAPS 13.20 12.04 11.86 11.20 11.88 10.32 9.64 5.37%
Adjusted Per Share Value based on latest NOSH - 1,185,341
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 232.88 212.14 190.53 159.85 144.37 174.93 210.14 1.72%
EPS 69.07 59.20 68.91 132.50 113.59 90.43 490.16 -27.84%
DPS 20.83 16.67 19.17 73.33 60.83 70.83 25.00 -2.99%
NAPS 11.0007 10.0333 9.8833 9.3334 9.9001 8.60 8.0333 5.37%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 16.14 11.60 17.16 17.26 15.96 9.30 11.00 -
P/RPS 5.78 4.56 7.51 9.00 9.21 4.43 4.36 4.80%
P/EPS 19.47 16.33 20.75 10.86 11.71 8.57 1.87 47.71%
EY 5.13 6.12 4.82 9.21 8.54 11.67 53.47 -32.31%
DY 1.55 1.72 1.34 5.10 4.57 9.14 2.73 -8.99%
P/NAPS 1.22 0.96 1.45 1.54 1.34 0.90 1.14 1.13%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 28/02/14 27/02/13 29/02/12 28/02/11 02/03/10 27/02/09 29/02/08 -
Price 15.92 12.22 17.20 16.50 16.16 9.70 10.80 -
P/RPS 5.70 4.80 7.52 8.60 9.33 4.62 4.28 4.88%
P/EPS 19.21 17.20 20.80 10.38 11.86 8.94 1.84 47.78%
EY 5.21 5.81 4.81 9.64 8.44 11.19 54.46 -32.34%
DY 1.57 1.64 1.34 5.33 4.52 8.76 2.78 -9.07%
P/NAPS 1.21 1.01 1.45 1.47 1.36 0.94 1.12 1.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment